We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+11.02%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$772M
AUM Growth
+$83.7M
Cap. Flow
+$20M
Cap. Flow %
2.59%
Top 10 Hldgs %
23.79%
Holding
277
New
30
Increased
91
Reduced
113
Closed
31

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.37M
2
UNH icon
UnitedHealth
UNH
+$6.9M
3
SYK icon
Stryker
SYK
+$5.97M
4
AMZN icon
Amazon
AMZN
+$5.71M
5
NVO
Novo Nordisk
NVO
+$4.09M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$6.39M
2
NXPI icon
NXP Semiconductors
NXPI
+$5.81M
3
ABT icon
Abbott
ABT
+$5.43M
4
SPLK
Splunk Inc
SPLK
+$5.14M
5
HOLX
Hologic
HOLX
+$5.09M

Sector Composition

Rank Sector Weight
1 Technology 21.16%
2 Healthcare 14.53%
3 Financials 8.29%
4 Industrials 8.18%
5 Communication Services 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
L icon
151
Loews
L
$23.1B
$786K 0.1%
11,295
-242
-2% -$16.1K
OPRX icon
152
OptimizeRx
OPRX
$132M
$782K 0.1%
54,675
+20,245
+59% +$194K
SWKH
153
DELISTED
SWK Holdings
SWKH
$778K 0.1%
55,992
-1,490
-3% -$19.4K
SMG icon
154
ScottsMiracle-Gro
SMG
$3.62B
$769K 0.1%
12,057
-181
-1% -$9.78K
ZS icon
155
Zscaler
ZS
$28.7B
$767K 0.1%
3,463
+553
+19% +$102K
APYX icon
156
Apyx Medical
APYX
$126M
$766K 0.1%
292,424
-9,385
-3% -$22.7K
PHLT
157
DELISTED
Performant Healthcare Inc
PHLT
$765K 0.1%
244,697
+70,682
+41% +$185K
SPXC icon
158
SPX Corp
SPXC
$10.9B
$737K 0.1%
7,297
-253
-3% -$21.9K
VCTR icon
159
Victory Capital Holdings
VCTR
$7.15B
$723K 0.09%
20,984
-486
-2% -$15.5K
CELH icon
160
Celsius Holdings
CELH
$6.99B
$711K 0.09%
13,038
+3,375
+35% +$180K
SMLR
161
DELISTED
Semler Scientific
SMLR
$702K 0.09%
15,847
-853
-5% -$30.6K
CNMD icon
162
CONMED
CNMD
$1.48B
$702K 0.09%
6,406
-154
-2% -$15.9K
EG icon
163
Everest Group
EG
$13.9B
$700K 0.09%
1,980
+354
+22% +$137K
DNOW icon
164
DNOW Inc
DNOW
$3.04B
$693K 0.09%
61,217
-2,043
-3% -$22.4K
HAYN
165
DELISTED
Haynes International, Inc.
HAYN
$664K 0.09%
11,639
-328
-3% -$15.8K
BLKB icon
166
Blackbaud
BLKB
$2.03B
$652K 0.08%
7,519
+1,581
+27% +$120K
MX icon
167
Magnachip Semiconductor
MX
$139M
$629K 0.08%
83,902
-319
-0.4% -$2.33K
VTI icon
168
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$625K 0.08%
2,636
– –
FR icon
169
First Industrial Realty Trust
FR
$8.4B
$620K 0.08%
11,764
-250
-2% -$11.6K
ENV
170
DELISTED
ENVESTNET, INC.
ENV
$620K 0.08%
12,512
-339
-3% -$13.9K
MGNI icon
171
Magnite
MGNI
$3.49B
$618K 0.08%
66,134
-1,122
-2% -$8.87K
COST icon
172
Costco
COST
$421B
$615K 0.08%
932
+213
+30% +$126K
TMO icon
173
Thermo Fisher Scientific
TMO
$223B
$611K 0.08%
1,151
-13,207
-92% -$6.39M
XLE icon
174
State Street Energy Select Sector SPDR ETF
XLE
$39.9B
$601K 0.08%
14,326
-334
-2% -$14.3K
STX icon
175
Seagate
STX
$199B
$598K 0.08%
+6,999
New +$522K
5 6
7
8 9

Similar funds

SVCP
Silicon Valley Capital Partners San Jose, California $1.02B AUM 21.85% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $1.02B AUM
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Greenwood Capital Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Greenwood Capital Associates held 277 positions worth $772M, up 12% from $688M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Greenwood Capital Associates's Q4 2023 filing shows 30 new, 91 increased, 113 reduced and 31 closed positions. Its largest new stake was UnitedHealth: 12,932 shares worth $6.81M. The largest sale was Thermo Fisher Scientific, an estimated $6.39M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Greenwood Capital Associates's largest Q4 2023 buy was UnitedHealth: 12,932 shares worth $6.81M.
  • Greenwood Capital Associates added most to Berkshire Hathaway Class B in Q4 2023, an estimated $8.37M increase.
  • Greenwood Capital Associates's biggest Q4 2023 reduction was Thermo Fisher Scientific, cutting an estimated $6.39M.
  • Greenwood Capital Associates fully exited NXP Semiconductors in Q4 2023, selling an estimated $5.81M.
  • Greenwood Capital Associates's ten largest holdings make up 24% of its $772M portfolio in Q4 2023.
  • Greenwood Capital Associates opened 30 new positions and closed 31 in Q4 2023.
  • Greenwood Capital Associates's portfolio value rose 12% quarter-over-quarter to $772M.

Based on Greenwood Capital Associates's 13F filing for Q4 2023, filed 5 Mar 2024.